Theraclion Company Description

Theraclion SA designs and markets high-tech therapeutic ultrasound equipment.

It offers SONOVEIN, a robotic solution for non-invasive echotherapy treatment of varicose veins; ECHOPULSE, a robotic and non-invasive solution for echotherapy treatment of thyroid nodules and breast fibroadenoma; and EPack, a disposable that is installed on the device before treatment and protects the patient’s skin and optimizes the image quality.

Theraclion SA was incorporated in 2004 and is based in Malakoff, France.

Theraclion SA

Country	France
Founded	2004
Industry	Medical Devices
Sector	Healthcare
Employees	29
CEO	Martin Deterre

Contact Details

Address: 244, avenue Pierre Brossolette Malakoff, 92240 France
Phone	33 1 55 48 90 70
Website	theraclion.com

Stock Details

Ticker Symbol	ALTHE
Exchange	Euronext Paris
Fiscal Year	January - December
Reporting Currency	EUR
ISIN Number	FR0010120402
SIC Code	3845

Key Executives

Name	Position
Martin Deterre	Chief Executive Officer
Yann M. Duchesne	Executive Chairman
Christophe Lamboeuf	Chief Financial Officer
Gaylord Tallec	Vice President of Operations
Jérémie Anquez	Vice President Research and Chief Scientific Officer
Jose Abellan-Martinez	Vice President of Sales and Business Development
Marie Berne	Marketing and Customer Relations Director
Michel Nuta M.D.	Vice President of Veins and Chief Medical Officer